Cargando…
Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
BACKGROUND: Metabolic syndrome in patients with schizophrenia is a major health concern. The efficacy and safety of adjunctive rosuvastatin in treating dyslipidemia were controversial. AIMS: To assess the efficacy and safety of adjunctive rosuvastatin for dyslipidemia in patients with schizophrenia....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Shanghai Municipal Bureau of Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925598/ https://www.ncbi.nlm.nih.gov/pubmed/29719353 http://dx.doi.org/10.11919/j.issn.1002-0829.217156 |